Memantine USP Related Compound D - CAS 941-37-7
Catalog: |
BB041208 |
Product Name: |
Memantine USP Related Compound D |
CAS: |
941-37-7 |
Synonyms: |
USP Memantine Related Compound D; Memantine Related Compound D; 1-Bromo-3,5-dimethyl-tricyclo[3.3.1.13,7]decane; Tricyclo[3.3.1.13,7]decane, 1-bromo-3,5-dimethyl-; 3,5-Dimethyl-1-bromoadamantane; NSC 102293; Adamantane, 1-bromo-3,5-dimethyl-; 1,3-Dimethyl-5-bromoadamantane |
Related CAS: | 1204184-77-9 (Deleted CAS)
|
IUPAC Name: | 1-bromo-3,5-dimethyladamantane |
Description: | Memantine USP Related Compound D is an impurity of Memantine, which is an N-methyl D-aspartate (NMDA) antagonist used to slow the progression of moderate-to-severe Alzheimer's disease. |
Molecular Weight: | 243.18 |
Molecular Formula: | C12H19Br |
Canonical SMILES: | CC12CC3CC(C1)(CC(C3)(C2)Br)C |
InChI: | InChI=1S/C12H19Br/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10/h9H,3-8H2,1-2H3 |
InChI Key: | QUCXLVDIVQWYJR-UHFFFAOYSA-N |
Boiling Point: | 67-69°C at 0.03 Torr |
Purity: | ≥95% |
Density: | 1.365±0.06 g/cm3 |
Solubility: | Soluble in Chloroform (Sparingly), Dichloromethane (Slightly), Methanol (Slightly) |
Appearance: | Colorless to Pale Yellow Oily Matter |
Storage: | Store at 2-8°C |
MDL: | MFCD00077197 |
LogP: | 4.13030 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-112341340-A | Green and efficient preparation method of medicine for treating Alzheimer's disease | 20200930 |
CN-111909041-A | Preparation method of medicine for treating neurological diseases | 20200812 |
CN-111701600-A | Catalyst for preparing 1-bromo-3, 5-dimethyl adamantane and application thereof | 20200702 |
CN-111233670-A | Memantine hydrochloride impurity compound and preparation method thereof | 20200309 |
WO-2021162746-A1 | Propylene polymers obtained using transition metal bis(phenolate) catalyst complexes and homogeneous process for production thereof | 20200211 |
Complexity: | 240 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 242.06701 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 0 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 242.06701 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 0 Å2 |
Undefined Atom Stereocenter Count: | 2 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 5 |
-
Catalog: BB079894
((3-Bromo-4-fluorophenyl)ethynyl)trimethylsilane
Detail
-
Catalog: BB044157
(+)-2,10-(3,3-dichlorocamphorsultam)
Detail
-
Catalog: BB054256
((2S,4R)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methanol
Detail
-
Catalog: BB044156
(-)-2,10-(3,3-dichlorocamphorsultam)
Detail
-
Catalog: BB017138
(1-Bromo-3-chloropropyl)benzene
Detail
-
Catalog: BB054190
(-)-(8,8-Dichlorocamphorylsulfonyl)oxaziridine
Detail
-
Catalog: BB078021
(1-(3-Bromo-5-fluorophenyl)cyclopropyl)methanamine
Detail
-
Catalog: BB030086
(1-Bromoethyl)benzene
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Halides
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS